Pharmacologically targetable vulnerability in prostate cancer carrying RB1-SUCLA2 deletion

Genome engineering using the CRISPR-Cas9 system

F. Ann Ran, Patrick D. Hsu, Jason Wright et al. · Nature Protocols · 2013 · 11.7K citations · Full text

Life Sciences, Genetics, Molecular Biology +14

Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters.

Marco Castagna, Yoshimi Takai, Kozo Kaibuchi et al. · Journal of Biological Chemistry · 1982 · 4.8K citations · Full text

Life Sciences, Biochemistry, Cell Biology +16

Integrative Genomic Profiling of Human Prostate Cancer

Barry S. Taylor, Nikolaus Schultz, Haley Hieronymus et al. · Cancer Cell · 2010 · 3.8K citations · Full text

Medicine, Genetics, Oncology +14

The mutational landscape of lethal castration-resistant prostate cancer

Catherine S. Grasso, Yi-Mi Wu, Dan R. Robinson et al. · Nature · 2012 · 2.6K citations

Medicine, Oncology, Urology +14

Genomic correlates of clinical outcome in advanced prostate cancer

Wassim Abida, Joanna Cyrta, Glenn Heller et al. · Proceedings of the National Academy of Sciences · 2019 · 1.4K citations · Full text

Medicine, Oncology, Urology +17